Biopharmaceuticals Market Size, Competitive Strategies, Application Analysis, Regional, and Forecasts 2019 To 2025

Biopharmaceuticals are drugs having a biological origin. These large and complex drugs, which often comprise heterogeneous mixtures, are produced using biotechnology and usually from genetically engineered cells. The global biopharmaceuticals market accounted for $186,470 million in 2017, and is projected to reach $526,008 million by 2025, registering a CAGR of 13.8% from 2018 to 2025.

Major Key Players of the Biopharmaceuticals Market are:
Abbott Laboratories, Amgen, Inc., Biogen, Inc., Eli Lilly and Company, F. Hoffmann-La Roche, Ltd., Johnson & Johnson, Merck & Co., Inc., Novo Nordisk A/S, Pfizer, Inc., Sanofi

Read More @ https://www.medgadget.com/2020/12/biopharmaceuticals-market-size-competitive-strategies-application-analysis-regional-and-forecasts-2019-to-2025.html



Comments

Popular posts from this blog

Strategic Developments in Semiconductor Foundry Technologies and Their Global Impact

How is Quantum AI Accelerating the Drug Discovery Process?

How Do Signal Generators Impact the Automotive and Wireless Sectors?